Spearheaded by dual English-French qualified Denis Schertenleib, who has a background in physics and molecular neurobiology, the team at Schertenleib has a wealth of experience handling complex litigation before the EPO, French courts, and the UPC. The firm has a specific penchant for advising large multinational pharmaceutical companies on their medical patent infringement, validity, and enforcement issues, and the group also handles filings. Marc Lauzeral is also a key name in the team, as well as Ombeline Degrèze-Péchade; both are seasoned litigators with significant pharmaceutical expertise.
Legal 500 Editorial commentary
Phone
+33 (0)1 42 66 66 00
Email
Profile

Profile

Position

Partner

Career

Denis Schertenleib is dual qualified to practice as a lawyer at the Paris Bar and as a Solicitor in England and Wales.

Prior to becoming a lawyer, he completed a BSc degree with First Class Honors in physics at Imperial College London and a PhD in molecular neurobiology at King’s College London.

He is an Associate of the Royal College of Science of London.

Denis specializes in patent litigation, arbitration, technology licensing, European competition law applied to intellectual property and regulatory law in the pharmaceutical field.

His practice involves multi-jurisdictional litigation both in the life sciences and in other areas of technology such as chemistry, mechanics, telecommunications and physics.

Denis has previously worked in an international law firm in the City of London and has been for several years, a partner in a leading IP law firm in Paris.

Languages

French, English

Education

Avocat at the Paris Bar
Solicitor of England and Wales
B.Sc. Physics
Ph.D. Molecular Biology

Content supplied by Schertenleib

Testimonials

Collated independently by Legal 500 research team.

  • ‘Excellent firm, with a great specialisation in IP. Also has understanding of UK/US clients.’
  • ‘Excellent individual lawyers.’

  • ‘The Cabinet Schertenleib team stands out in life sciences and pharmaceutical patent litigation, with an impressive team of experts in this field. Their strength lies in the rare combination of both legal and scientific knowledge, allowing them to handle complex cases more efficiently than other firms.'

  • 'The firm's strong international connections make them ideal for handling complicated cross-border cases. They are definitely the go-to address for pharmaceutical patent litigation in France.’

  • ‘Denis Schertenleib's exceptional scientific background (physics and molecular neurobiology) combined with his extensive legal experience and his negotiating skills, makes him a standout leader in complex, high-stake cases.'

  • 'Ombeline Degrèze-Péchade's strength is a unique combination of scientific expertise and exceptional legal skills as well as her impressive knowledge of regulatory and patent law which makes her an excellent patent litigator and brilliant strategic advisor.'
  • '‘The most sophisticated patent firm at the French bar.’

Key clients

  • Recor Medical Inc. & Otsuka Medical Device
  • Viatris
  • Neuraxpharm
  • Sandoz
  • Zentiva
  • Sodel
  • Zentiva
  • C-KORE
  • Filorga
  • HLD
  • Fill-Med
  • TCL
  • Bio-Rad
  • Polpharma